Real-Time Adherence Monitoring for HIV Antiretroviral Therapy
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Current adherence assessments typically detect missed doses long after they occur. Real-time, wireless monitoring strategies for antiretroviral therapy may provide novel opportunities to proactively prevent virologic rebound and treatment failure. Wisepill, a wireless pill container that transmits a cellular signal when opened, was pilot tested in ten Ugandan individuals for 6 months. Adherence levels measured by Wisepill, unannounced pill counts, and self-report were compared with each other, prior standard electronic monitoring, and HIV RNA. Wisepill data was initially limited by battery life and signal transmission interruptions. Following device improvements, continuous data was achieved with median (interquartile range) adherence levels of 93% (87-97%) by Wisepill, 100% (99-100%) by unannounced pill count, 100% (100-100%) by self-report, and 92% (79-98%) by prior standard electronic monitoring. Four individuals developed transient, low-level viremia. After overcoming technical challenges, real-time adherence monitoring is feasible for resource-limited settings and may detect suboptimal adherence prior to viral rebound.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perceived usefulness, perceived ease of use, and user acceptance of information technology
Davis, F. D. (1989) · MIS Quarterly · doi:10.2307/249008 · Cited by 68,483
The Technology Acceptance Model: Its past and its future in health care
Holden, R. J., & Karsh, B.-T. (2010) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2009.07.002 · Cited by 2,669
‘Mobile’ Health Needs And Opportunities In Developing Countries
Kahn, J. G., Yang, J. S., & Kahn, J. S. (2010) · Health Affairs · doi:10.1377/hlthaff.2009.0965 · Cited by 408 · cited 1×
“While excitement abounds for wireless technologies to support healthcare delivery, especially in developing settings, few studies have provided evidence of feasibility, acceptability, and performance [7].”
Background
Cited by
Vervloet, M., Linn, A. J., van Weert, J. C. M., de Bakker, D. H., Bouvy, M. L., & van Dijk, L. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000748 · Cited by 455
Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm
Haberer, J. E., Bangsberg, D. R., Baeten, J. M., Curran, K., Koechlin, F., Amico, K. R., Anderson, P., Mugo, N., Venter, F., Goicochea, P., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000647 · Cited by 319
Self-citationAssessing medication adherence: options to consider
Lehmann, A., Aslani, P., Ahmed, R., Celio, J., Gauchet, A., Bedouch, P., Bugnon, O., Allenet, B., & Schneider, M. P. (2014) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-013-9865-x · Cited by 318
HIV prevention transformed: the new prevention research agenda
Padian, N. S., McCoy, S. I., Karim, S. S. A., Hasen, N., Kim, J., Bartos, M., Katabira, E., Bertozzi, S. M., Schwartländer, B., & Cohen, M. S. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60877-5 · Cited by 295
Iacob, S. A., Iacob, D. G., & Jugulete, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00831 · Cited by 265
Lankowski, A. J., Siedner, M. J., Bangsberg, D. R., & Tsai, A. C. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0729-8 · Cited by 260
Self-citationBhana, A., Mellins, C. A., Petersen, I., Alicea, S., Myeza, N., Holst, H., Abrams, E., John, S., Chhagan, M., Nestadt, D. F., et al. (2014) · AIDS Care · doi:10.1080/09540121.2013.806770 · Cited by 235
“The challenges adolescents face with non-adherence to medical treatment are compounded for YLWPHIV by HIV stigma, ART side effects, lifelong need for medication (Haberer et al., 2010; Mills et al., 2006), sexual development and behavior compromised by early and lifetime exposure to HIV and treatment (Bauermeister, Elk…”
BackgroundVervloet, M., van Dijk, L., Santen-Reestman, J., van Vlijmen, B., van Wingerden, P., Bouvy, M. L., & de Bakker, D. H. (2012) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2012.05.005 · Cited by 215
A Proposal for Quality Standards for Measuring Medication Adherence in Research
Williams, A. B., Amico, K. R., Bova, C., & Womack, J. A. (2013) · AIDS and Behavior · doi:10.1007/s10461-012-0172-7 · Cited by 198
“The advantages of EMDs include: measurement of adherence in real time [48, 49], tracking the timing of missed doses [50], avoidance of error due to recall or memory associated with self-report [51–53], evaluating medication dose response [42] and the ability to identify patterns of adherence behavior that would be dif…”
Coffin, P. O., Santos, G.-M., Hern, J., Vittinghoff, E., Walker, J. E., Matheson, T., Santos, D., Colfax, G., & Batki, S. L. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3655 · Cited by 139
Andersen, L. S., Magidson, J. F., O’Cleirigh, C., Remmert, J. E., Kagee, A., Leaver, M., Stein, D. J., Safren, S. A., & Joska, J. (2018) · Journal of Health Psychology · doi:10.1177/1359105316643375 · Cited by 84
Magidson, J. F., Joska, J. A., Belus, J. M., Andersen, L. S., Regenauer, K. S., Rose, A. L., Myers, B., Majokweni, S., O’Cleirigh, C., & Safren, S. A. (2021) · Journal of the International AIDS Society · doi:10.1002/jia2.25720 · Cited by 82
“Finally, although real-time electronic adherence monitoring is a strength, it has its limitations; Wisepill can act as an intervention in itself, and non-use of Wisepill may be conflated with ART non-adherence – although we limited our assessment to three months to minimize potential non-use over time [29].”
BackgroundMethodInfluentialBright, E. E., Finkelstein, L. B., Nealis, M. S., Genung, S. R., Wrigley, J., Gu, H. C. J., Schmiege, S. J., & Arch, J. J. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00697 · Cited by 74
Recent Advances (2011-2012) in Technology-Delivered Interventions for People Living with HIV
Pellowski, J. A., & Kalichman, S. C. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-012-0133-9 · Cited by 66
Beauchemin, M., Gradilla, M., Baik, D., Cho, H., & Schnall, R. (2019) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2018.11.012 · Cited by 58
“In addition, real-time medication monitoring is important for medication reminder systems and it is both feasible and acceptable to PLWH (14).”
BackgroundMethodde Sumari-de Boer, I. M., van den Boogaard, J., Ngowi, K. M., Semvua, H. H., Kiwango, K. W., Aarnoutse, R. E., Nieuwkerk, P. T., & Kibiki, G. S. (2016) · AIDS and Behavior · doi:10.1007/s10461-015-1254-0 · Cited by 40
Haberer, J. E., Trabin, T., & Klinkman, M. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.03.009 · Cited by 39
Self-citationOptimizing Network Connectivity for Mobile Health Technologies in sub-Saharan Africa
Siedner, M. J., Lankowski, A., Musinga, D., Jackson, J., Muzoora, C., Hunt, P. W., Martin, J. N., Bangsberg, D. R., & Haberer, J. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045643 · Cited by 36
Self-citationArch, J. J., Crespi, C. M., Levin, M. E., Genung, S. R., Nealis, M., Mitchell, J. L., Bright, E. E., Albright, K., Magidson, J. F., & Stanton, A. L. (2022) · Annals of Behavioral Medicine · doi:10.1093/abm/kaab118 · Cited by 34
Sumari-de Boer, M., Pima, F. M., Ngowi, K. M., Chelangwa, G. M., Mtesha, B. A., Minja, L. M., Semvua, H. H., Mpagama, S., Mmbaga, B. T., Nieuwkerk, P. T., et al. (2019) · Trials · doi:10.1186/s13063-019-3483-4 · Cited by 27
Dreyer, A. J., Nightingale, S., Andersen, L. S., Lee, J. S., Gouse, H., Safren, S. A., O’Cleirigh, C., Thomas, K. G. F., & Joska, J. (2023) · AIDS and Behavior · doi:10.1007/s10461-023-03992-7 · Cited by 3
“Wisepill technology is a feasible way of monitoring ART adherence objectively and in real time [42, 75].”
Background
Metadata
- Authors
- Haberer, J. E., Kahane, J., Kigozi, I., Emenyonu, N., Hunt, P., Martin, J., & Bangsberg, D. R.
- Venue
- AIDS and Behavior
- Published
- 2010-08-31
- Volume
- 14
- Issue
- 6
- Pages
- 1340-1346
- ISSN
- 1090-7165 (ISSN-L)
- 1573-3254
- OpenAlex
- W2109168061
- Cited by
- 231
- References
- 3
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.